2015 APHA Annual Meeting & Expo

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

339574
Overview and History of Sickle Cell Disease in the United States


Tuesday, November 3, 2015 : 10:30 a.m. - 10:50 a.m.

Gabrielle Young, A. A., University of Illinois at Chicago, Chicago, IL
Audio (mp3) recording Recorded Presentation (mp4)
Sickle Cell Disease (SCD affects 90,000 to 100,000 Americans, occurs 1 in 500 Black or African-American births, and 1 in every 36,000 Hispanic-American births.  Approximately 1 in 12 Blacks or African Americans, National Heart, Lung, and Blood Institute; 2009.  This presentation will provide an overview of the history of sickle cell disease in the United States and the significance that Chicago has played in treatment and management of the disease.  Presentation will include relevant statistics regarding morbidity and mortality of the disease and major advancements in treatment and research, and how the Affordable Care Act helps/hinders patients with sickle cell disease

Learning Areas:

Chronic disease management and prevention
Other professions or practice related to public health

Learning Objectives:
Describe the history of Sickle Cell Disease among racial and ethnic minorities in the United States.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am an undergraduate student at UIC and have a family history of SCD and SCT. As a participant in the Urban Health Program I recently completed a summer research where I worked with SCD researchers on SCD research. I am qualified to speak on this subject due to my personal experience with the disease and my experience working in the UIC.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4102.0: The Burden of Treatment: Literature Review and Personal Perspective of a Patient with Sickle Cell Disease Seeking Care in the Emergency Room